[go: up one dir, main page]

ES2115656T3 - Analogos de tocoferol cardioprotectores. - Google Patents

Analogos de tocoferol cardioprotectores.

Info

Publication number
ES2115656T3
ES2115656T3 ES92402656T ES92402656T ES2115656T3 ES 2115656 T3 ES2115656 T3 ES 2115656T3 ES 92402656 T ES92402656 T ES 92402656T ES 92402656 T ES92402656 T ES 92402656T ES 2115656 T3 ES2115656 T3 ES 2115656T3
Authority
ES
Spain
Prior art keywords
cardioprotectors
tocoferol
analogs
cardioprotectoral
phosphony
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92402656T
Other languages
English (en)
Inventor
J Martin Grisar
Margaret A Petty
Frank Bolkenius
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2115656T3 publication Critical patent/ES2115656T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Inspection Of Paper Currency And Valuable Securities (AREA)
  • Noodles (AREA)
  • Credit Cards Or The Like (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Cosmetics (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Fire-Detection Mechanisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA INVENCION SE REFIERE A DERIVADOS DEL ALQUILENO DE FOSFONIO ALQUILATADOS DE CIERTOS 2H-1-BENZOPIRANOS, A SUBSTANCIAS INTERMEDIAS Y A PROCESOS UTILES PARA SU PREPARACION, A SUBSTANCIAS CAPTADORES DEL RADICAL LIBRE Y A SUS PROPIEDADES CARDIOPROTECTORAS Y A SU USO FINAL COMO AGENTES TERAPEUTICOS.
ES92402656T 1991-10-02 1992-09-29 Analogos de tocoferol cardioprotectores. Expired - Lifetime ES2115656T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91402630A EP0535283A1 (en) 1991-10-02 1991-10-02 Cardioprotective tocopherol analogs

Publications (1)

Publication Number Publication Date
ES2115656T3 true ES2115656T3 (es) 1998-07-01

Family

ID=8208620

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92402656T Expired - Lifetime ES2115656T3 (es) 1991-10-02 1992-09-29 Analogos de tocoferol cardioprotectores.

Country Status (17)

Country Link
EP (2) EP0535283A1 (es)
JP (1) JP3230699B2 (es)
KR (1) KR100253108B1 (es)
AT (1) ATE163421T1 (es)
AU (1) AU652077B2 (es)
CA (1) CA2079289C (es)
DE (1) DE69224501T2 (es)
DK (1) DK0536036T3 (es)
ES (1) ES2115656T3 (es)
FI (1) FI105552B (es)
GR (1) GR3026242T3 (es)
HU (1) HU215123B (es)
IL (1) IL103305A0 (es)
NO (1) NO923840L (es)
NZ (1) NZ244549A (es)
TW (1) TW224970B (es)
ZA (1) ZA927429B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721233A (en) * 1992-04-06 1998-02-24 Merrell Pharmaceuticals Inc. Derivatives of 2,3-dihydro benzofuranols
US5510373A (en) * 1992-04-06 1996-04-23 Merrell Pharmaceuticals Inc. Cardioprotective agents
US5545660A (en) * 1992-04-07 1996-08-13 Merrell Pharmaceuticals Inc. Hydrazide derivatives of 3,4-dihydro-2H-1-benzopyrans
AU763179B2 (en) * 1997-11-25 2003-07-17 Antipodean Pharmaceuticals, Inc. Mitochondrially targeted antioxidants
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
MXPA04000654A (es) 2001-07-27 2004-03-19 Vital Health Sciences Pty Ltd Terapia dermica usando derivados de fosfato de agente de transferencia de electrones.
EP1374882B1 (de) * 2002-06-19 2008-10-01 Cognis IP Management GmbH Verwendung von Wirkstoffgemischen zur Herstellung eines Medikamentes gegen rheumatische Arthritis
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
IL173807A (en) 2003-08-22 2014-02-27 Antipodean Pharmaceuticals Inc Antioxidant amphiphilic compounds, histoquinone history and pharmaceutical preparations containing them
US7888334B2 (en) 2003-08-22 2011-02-15 Antipodean Pharmaceuticals, Inc. Mitoquinone derivatives used as mitochondrially targeted antioxidants
US7470798B2 (en) 2003-09-19 2008-12-30 Edison Pharmaceuticals, Inc. 7,8-bicycloalkyl-chroman derivatives
DE602005025979D1 (de) 2004-03-03 2011-03-03 Vital Health Sciences Pty Ltd Alkaloid-formulierungen
CA2611831C (en) 2005-06-17 2014-09-16 Vital Health Sciences Pty Ltd. A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
US7813042B2 (en) 2005-09-12 2010-10-12 Sharp Kabushiki Kaisha Multiple-view directional display
US8687273B2 (en) 2006-09-07 2014-04-01 Sharp Kabushiki Kaisha Image display device, electronic device, and parallax barrier element
AU2011213557B2 (en) 2010-02-05 2015-05-07 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
EP2552486B1 (en) 2010-03-30 2020-08-12 Phosphagenics Limited Transdermal delivery patch
US9561243B2 (en) 2011-03-15 2017-02-07 Phosphagenics Limited Composition comprising non-neutralised tocol phosphate and a vitamin A compound
US10973761B2 (en) 2015-12-09 2021-04-13 Phosphagenics Limited Pharmaceutical formulation
KR102647670B1 (ko) 2016-12-21 2024-03-15 아베초 바이오테크놀로지 리미티드 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62205091A (ja) * 1986-03-04 1987-09-09 Senjiyu Seiyaku Kk 新規なリン酸ジエステルならびにその塩、その製造法およびそれを含有する製剤
CA2002649C (en) * 1988-11-14 2000-06-06 Margaret Petty Cardioprotective tocopherol analogs
US5500444A (en) 1989-11-14 1996-03-19 Hoechst Marion Roussel, Inc. Cardioprotective tocopherol analogs
US5135945A (en) 1991-06-05 1992-08-04 Merrell Dow Pharmaceuticals Inc. Cholesterol-lowering tocopherol analogs

Also Published As

Publication number Publication date
IL103305A0 (en) 1993-02-21
FI105552B (fi) 2000-09-15
CA2079289C (en) 2003-02-18
GR3026242T3 (en) 1998-05-29
EP0535283A1 (en) 1993-04-07
NO923840D0 (no) 1992-10-01
DE69224501T2 (de) 1998-06-25
FI924424A0 (fi) 1992-10-01
EP0536036B1 (en) 1998-02-25
JPH05310763A (ja) 1993-11-22
JP3230699B2 (ja) 2001-11-19
NO923840L (no) 1993-04-05
NZ244549A (en) 1994-07-26
HU215123B (hu) 1998-09-28
HU9203134D0 (en) 1992-12-28
DK0536036T3 (da) 1998-03-16
ATE163421T1 (de) 1998-03-15
AU652077B2 (en) 1994-08-11
AU2538392A (en) 1993-04-08
CA2079289A1 (en) 1993-04-03
DE69224501D1 (de) 1998-04-02
EP0536036A1 (en) 1993-04-07
TW224970B (es) 1994-06-11
HUT62592A (en) 1993-05-28
KR100253108B1 (ko) 2000-05-01
FI924424L (fi) 1993-04-03
ZA927429B (en) 1993-04-07

Similar Documents

Publication Publication Date Title
ES2115656T3 (es) Analogos de tocoferol cardioprotectores.
ES2111092T3 (es) Derivados de acidos biliares, procedimiento para su preparacion y utilizacion de estos compuestos como medicamentos.
ES2116594T3 (es) Ansamicinas biciclicas y su uso como agentes antitumorales.
ES2176212T3 (es) Eteres de fosfonooximetilicos o metiltiometilicos de derivados de taxano como agentes antitumorales.
SV1995000042A (es) Heteroaril-oxazolidinonas de 5 eslabones ref. le a 30523-sv
ES542322A0 (es) Un procedimiento para la preparacion de derivados de la 2 pirimidinil-1-piperazina
ES2106965T3 (es) Nuevas 4-aza-5alfa-androstan-3-onas 7beta-sustituidas como inhibidores de 5alfa-reductasa.
ES2138956T3 (es) Imidazoquinoxalinonas, sus analogos aza y procedimiento para su preparacion.
ES2141559T3 (es) Derivados de 2-ciano-1-sulfonamidofenil-1,3-diona y su uso como herbicidas.
ES2119831T3 (es) 7-(sustituido)-9-((glicil sustituido)amido)-6-desmetil-6-desoxitetraciclinas.
ES2030409T3 (es) Procedimiento para preparar y purificar compuestos termolabiles .
ES2098140T3 (es) Liosferas que contienen gonadotropina.
ES2068179T3 (es) Benzo(5,6)-ciclohepta-piridinas, composiciones y metodo de uso.
ES2040727T3 (es) Un proceso para preparar una formulacion en aerosol en solucion de un analogo.
ES2136725T3 (es) Utilizacion de 2-amino-6-n-propil-amino-4,5,6,7-tetrahidrobenzotiazol (pramipexol) como medicamento con efecto antidepresivo.
MX9403915A (es) Derivados de n-alquiltio de pliamina como agentes radioprotectores.
ES2071674T3 (es) Analogos de tocoferol cardioprotectores.
ES2043665T3 (es) 6,11-dihidro-11-(4-piperidiliden)-5h-benzo-(5,6)-ciclohepta-(1,2-b)-piridinas y composiciones y metodos de uso.
IT8322080A0 (it) Derivati del n-fenilpirazolo utili come erbicidi.
ES2069921T3 (es) Antagonistas del nmda.
ES2054881T3 (es) Pantetina como agente inhibidor de la fibrosis hepatica.
ES2038163T3 (es) Procedimiento para preparar 1,3-dioxolanos trisustituidos en 2,4,4 y tetrasustituidos en 2,2,4,4.
UY24596A1 (es) Nuevos derivados sintéticos del catecol
MX9706744A (es) Proceso novedosos para preparar derivados de 2,3-dihidro-benzofuranol.
ES2059396T3 (es) Derivados de indeno y metodos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 536036

Country of ref document: ES